Japan, July 1 -- BIRDIE BIOPHARMACEUTICALS INC has got intellectual property rights for 'ANTI-PD-L1 COMBINATIONS FOR TREATING TUMORS.' Other related details are as follows:

Application Number: JP,2025-018420

Category (FI): A61P35/00,A61K39/395@T,A61K39/395@E,C07K16/28,A61P43/00,121,A61K31/4745

Stage: Grant (IP right granted following substantive examination.)

Filing Date: Feb. 6, 2025

Publication Date: April 17, 2025

The original document can be viewed at: https://www.j-platpat.inpit.go.jp/p0100

Disclaimer: Curated by HT Syndication....